SunTrust Banks Analysts Give Express Scripts (ESRX) a $86.00 Price Target

Express Scripts (NASDAQ:ESRX) has been assigned a $86.00 price objective by equities research analysts at SunTrust Banks in a note issued to investors on Thursday, December 21st. The brokerage currently has a “buy” rating on the stock. SunTrust Banks’ price objective indicates a potential upside of 6.34% from the company’s current price. SunTrust Banks also issued estimates for Express Scripts’ Q4 2017 earnings at $2.10 EPS, Q2 2018 earnings at $1.90 EPS, Q3 2018 earnings at $2.09 EPS, Q4 2018 earnings at $2.31 EPS, FY2018 earnings at $7.78 EPS, Q2 2019 earnings at $2.09 EPS, Q3 2019 earnings at $2.26 EPS and FY2019 earnings at $8.44 EPS.

Other research analysts also recently issued research reports about the company. Mizuho set a $67.00 price target on Express Scripts and gave the stock a “hold” rating in a research note on Tuesday, October 24th. Robert W. Baird reiterated a “hold” rating and set a $56.00 price target on shares of Express Scripts in a research note on Friday, September 1st. Raymond James Financial reissued a “sell” rating on shares of Express Scripts in a report on Friday, December 15th. Needham & Company LLC reissued a “hold” rating on shares of Express Scripts in a report on Thursday, December 21st. Finally, Royal Bank of Canada assumed coverage on Express Scripts in a report on Tuesday, September 19th. They set a “sector perform” rating and a $68.00 price objective on the stock. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $77.09.

Express Scripts (NASDAQ:ESRX) opened at $80.87 on Thursday. The stock has a market capitalization of $45,360.00, a price-to-earnings ratio of 13.43, a price-to-earnings-growth ratio of 0.89 and a beta of 0.87. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. Express Scripts has a 12 month low of $55.80 and a 12 month high of $81.75.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.90. The firm had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The business’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.74 EPS. equities research analysts expect that Express Scripts will post 7.04 earnings per share for the current fiscal year.

Express Scripts declared that its Board of Directors has approved a stock repurchase plan on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to repurchase shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its shares are undervalued.

In related news, CEO Timothy C. Wentworth purchased 8,000 shares of Express Scripts stock in a transaction that occurred on Tuesday, October 31st. The shares were acquired at an average cost of $61.13 per share, for a total transaction of $489,040.00. Following the transaction, the chief executive officer now directly owns 98,628 shares in the company, valued at $6,029,129.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Phyllis S. Anderson sold 643 shares of the firm’s stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total value of $40,103.91. The disclosure for this sale can be found here. Insiders have sold a total of 17,644 shares of company stock worth $1,289,609 over the last quarter. Corporate insiders own 0.68% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. CAPROCK Group Inc. grew its position in shares of Express Scripts by 0.9% in the 2nd quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock worth $235,000 after buying an additional 33 shares during the last quarter. Sandy Spring Bank lifted its stake in shares of Express Scripts by 0.6% in the 2nd quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock valued at $413,000 after purchasing an additional 37 shares during the period. Honkamp Krueger Financial Services Inc. lifted its stake in shares of Express Scripts by 0.8% in the 2nd quarter. Honkamp Krueger Financial Services Inc. now owns 4,762 shares of the company’s stock valued at $304,000 after purchasing an additional 38 shares during the period. Buckingham Asset Management LLC lifted its stake in shares of Express Scripts by 0.6% in the 2nd quarter. Buckingham Asset Management LLC now owns 8,874 shares of the company’s stock valued at $567,000 after purchasing an additional 52 shares during the period. Finally, Pitcairn Co. lifted its stake in shares of Express Scripts by 0.6% in the 2nd quarter. Pitcairn Co. now owns 13,183 shares of the company’s stock valued at $842,000 after purchasing an additional 79 shares during the period. Hedge funds and other institutional investors own 88.28% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/13/express-scripts-esrx-receives-buy-rating-from-suntrust-banks.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply